Barbara A. Parker

12.3k total citations · 3 hit papers
128 papers, 7.2k citations indexed

About

Barbara A. Parker is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Barbara A. Parker has authored 128 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 86 papers in Oncology, 42 papers in Pulmonary and Respiratory Medicine and 31 papers in Cancer Research. Recurrent topics in Barbara A. Parker's work include Cancer survivorship and care (32 papers), Cancer Risks and Factors (27 papers) and Cancer-related cognitive impairment studies (22 papers). Barbara A. Parker is often cited by papers focused on Cancer survivorship and care (32 papers), Cancer Risks and Factors (27 papers) and Cancer-related cognitive impairment studies (22 papers). Barbara A. Parker collaborates with scholars based in United States, Netherlands and United Kingdom. Barbara A. Parker's co-authors include George R. Stark, Loki Natarajan, Ruth E. Patterson, Sonia Ancoli‐Israel, Georgia Robins Sadler, Lianqi Liu, John P. Pierce, Richard B. Schwab, Razelle Kurzrock and Joel E. Dimsdale and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Barbara A. Parker

124 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Regulation of Simian Virus 40 Transcription: Sensitive Analysis of the RNA Species Present Early in Infections by Virus or Viral DNA

1979 592 citations Barbara A. Parker et al. profile →
[15] Detection of specific RNAs or specific fragments of DNA by fractionation in gels and transfer to diazobenzyloxymethyl paper

1979 502 citations Barbara A. Parker et al. profile →
Randomized Trial of a Fitbit-Based Physical Activity Intervention for Women

2015 345 citations Lisa Cadmus‐Bertram, Bess H. Marcus et al. profile →

Peers

Barbara A. Parker

ONCOL

PRM

PHYSI

Bradley E. Aouizerat United States

Nathan A. Berger United States

Sanjay Shete United States

Kathleen M. Egan United States

Ernest Choy United Kingdom

Theodoros Ν. Sergentanis Greece

Julia Stingl Germany

Laurence M. Demers United States

Katja Fall Sweden

Bradley E. Aouizerat United States

Barbara A. Parker

3.0k ×0.9

ONCOL

1.2k ×0.7

1.5k ×1.0

PRM

560 ×0.4

765 ×0.7

PHYSI

Citations per year, relative to Barbara A. Parker Barbara A. Parker (= 1×) peers Bradley E. Aouizerat

Countries citing papers authored by Barbara A. Parker

Since Specialization

Citations

This map shows the geographic impact of Barbara A. Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara A. Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara A. Parker more than expected).

Fields of papers citing papers by Barbara A. Parker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara A. Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara A. Parker. The network helps show where Barbara A. Parker may publish in the future.

Co-authorship network of co-authors of Barbara A. Parker

This figure shows the co-authorship network connecting the top 25 collaborators of Barbara A. Parker. A scholar is included among the top collaborators of Barbara A. Parker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Barbara A. Parker. Barbara A. Parker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Luker, Kathryn E., et al.. (2024). Growth signaling autonomy in circulating tumor cells aids metastatic seeding. PNAS Nexus. 3(2). pgae014–pgae014. 4 indexed citations

Kelly, Marcus R., Samson Fong, John J. Y. Lee, et al.. (2024). A deep learning model of tumor cell architecture elucidates response and resistance to CDK4/6 inhibitors. Nature Cancer. 5(7). 996–1009. 20 indexed citations

Shatsky, Rebecca, Teresa Helsten, Richard B. Schwab, et al.. (2024). A phase 1b study of zilovertamab in combination with paclitaxel for locally advanced/unresectable or metastatic HER2-negative breast cancer. Breast Cancer Research. 26(1). 32–32. 7 indexed citations

Basu, Amrita, Thomas Jones, Timothy D. Brown, et al.. (2023). 374P Evaluation of symptom severity, tolerability, and physical function in the I-SPY2 trial. Annals of Oncology. 34. S332–S333. 1 indexed citations

Hogarth, Michael, Allison Stover Fiscalini, Laura van ‘t Veer, et al.. (2023). Early Ascertainment of Breast Cancer Diagnoses Comparing Self-Reported Questionnaires and Electronic Health Record Data Warehouse: The WISDOM Study. JCO Clinical Cancer Informatics. 7(7). e2300019–e2300019.

Bardia, Aditya, Ingrid A. Mayer, Eric P. Winer, et al.. (2022). The oral selective estrogen receptor degrader GDC-0810 (ARN-810) in postmenopausal women with hormone receptor-positive HER2-negative (HR + /HER2 −) advanced/metastatic breast cancer. Breast Cancer Research and Treatment. 197(2). 319–331. 14 indexed citations

Shatsky, Rebecca, Barbara A. Parker, Nam Q. Bui, et al.. (2019). Next-Generation Sequencing of Tissue and Circulating Tumor DNA: The UC San Diego Moores Center for Personalized Cancer Therapy Experience with Breast Malignancies. Molecular Cancer Therapeutics. 18(5). 1001–1011. 34 indexed citations

Hartman, Sheri J., Lauren S Weiner, Sandahl H. Nelson, et al.. (2019). Mediators of a Physical Activity Intervention on Cognition in Breast Cancer Survivors: Evidence From a Randomized Controlled Trial. JMIR Cancer. 5(2). e13150–e13150. 26 indexed citations

Pu, Minya, Karen Messer, Sherri R. Davies, et al.. (2019). Research-based PAM50 signature and long-term breast cancer survival. Breast Cancer Research and Treatment. 179(1). 197–206. 62 indexed citations

10.

Hartman, Sheri J., Sandahl H. Nelson, Catherine R. Marinac, et al.. (2019). The effects of weight loss and metformin on cognition among breast cancer survivors: Evidence from the Reach for Health study. Psycho-Oncology. 28(8). 1640–1646. 18 indexed citations

11.

Nelson, Sandahl H., Lauren S Weiner, Loki Natarajan, et al.. (2019). Continuous, objective measurement of physical activity during chemotherapy for breast cancer: the Activity in Treatment pilot study. Translational Behavioral Medicine. 10(4). 1031–1038. 19 indexed citations

12.

Millis, Sherri Z., David Piccioni, Paul T. Fanta, et al.. (2017). Next-Generation Sequencing in the Clinical Setting Clarifies Patient Characteristics and Potential Actionability. Cancer Research. 77(22). 6313–6320. 22 indexed citations

13.

Schwaederlé, Maria, Hatim Husain, Paul T. Fanta, et al.. (2016). Use of Liquid Biopsies in Clinical Oncology: Pilot Experience in 168 Patients. Clinical Cancer Research. 22(22). 5497–5505. 102 indexed citations

14.

Schwaederlé, Maria, Barbara A. Parker, Richard B. Schwab, et al.. (2016). Precision Oncology: The UC San Diego Moores Cancer Center PREDICT Experience. Molecular Cancer Therapeutics. 15(4). 743–752. 125 indexed citations

15.

Schwaederlé, Maria, Gregory A. Daniels, David Piccioni, et al.. (2015). On the Road to Precision Cancer Medicine: Analysis of Genomic Biomarker Actionability in 439 Patients. Molecular Cancer Therapeutics. 14(6). 1488–1494. 71 indexed citations

16.

Cadmus‐Bertram, Lisa, et al.. (2015). Use of the Fitbit to Measure Adherence to a Physical Activity Intervention Among Overweight or Obese, Postmenopausal Women: Self-Monitoring Trajectory During 16 Weeks. JMIR mhealth and uhealth. 3(4). e96–e96. 122 indexed citations

17.

Patterson, Ruth E., Shirley W. Flatt, Vicky A. Newman, et al.. (2010). Marine Fatty Acid Intake Is Associated with Breast Cancer Prognosis,. Journal of Nutrition. 141(2). 201–206. 71 indexed citations

18.

Smith, Sonali M., Bruce D. Cheson, George P. Canellos, et al.. (2009). Recombinant interferon-α2b added to oral cyclophosphamide either as induction or maintenance in treatment-naive follicular lymphoma: final analysis of CALGB 8691. Leukemia & lymphoma. 50(10). 1606–1617. 5 indexed citations

19.

Pierce, John P., Loki Natarajan, Bette J. Caan, et al.. (2009). Dietary change and reduced breast cancer events among women without hot flashes after treatment of early-stage breast cancer: subgroup analysis of the Women’s Healthy Eating and Living Study. American Journal of Clinical Nutrition. 89(5). 1565S–1571S. 51 indexed citations

20.

Pierce, John P., Marcia L. Stefanick, Shirley W. Flatt, et al.. (2007). Greater Survival After Breast Cancer in Physically Active Women With High Vegetable-Fruit Intake Regardless of Obesity. Journal of Clinical Oncology. 25(17). 2345–2351. 309 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact